Oscar Health
In Mason Hawkins's portfolio · Longleaf Partners
Ticker OSCR
Not in the portfolio as of Q3 2026. Every quarter it shows up in a Longleaf Partners 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2025 | Sell | 0 | |
| Q2 2025 | Reduce 58% | 881,857 | 1.0% |
| Q1 2025 | Reduce 33% | 2,096,785 | 1.5% |
| Q4 2024 | Add 52% | 3,131,084 | 2.0% |
| Q3 2024 | Reduce 14% | 2,057,725 | 2.1% |
| Q2 2024 | Reduce 22% | 2,401,192 | 1.7% |
| Q1 2024 | Reduce 46% | 3,071,452 | 1.8% |
| Q4 2023 | Reduce 23% | 5,718,273 | 2.0% |
| Q3 2023 | Add 25% | 7,407,281 | 1.5% |
| Q2 2023 | Reduce 46% | 5,919,220 | 1.7% |
| Q1 2023 | Reduce 25% | 10,930,083 | 2.4% |
| Q4 2022 | Add 31% | 14,576,904 | 1.3% |
| Q3 2022 | No change | 11,146,872 | 1.4% |
| Q2 2022 | No change | 11,146,872 | 1.0% |
| Q1 2022 | Add 22% | 11,146,872 | 2.0% |
| Q4 2021 | Buy | 9,109,822 | 1.2% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.